FULGENT GENETICS’ INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud | News

NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). If you purchased or otherwise acquired Fulgent securities during the period March 22, 2019 and August 4, 2022, inclusive (the “Class Period”) … Read more

FULGENT GENETICS’ INVESTOR ALERT: Kaplan Fox Investigates

NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). If you purchased or otherwise acquired Fulgent securities during the period March 22, 2019 and August 4, 2022, inclusive (the “Class Period”) and would … Read more